SCHEMBL691982

SCHEMBL691982

CC=CC(=O)Nc1cccc(Nc2cc(Nc3ccc(Oc4ccccc4)cc3)ncn2)n1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 1/20 0.51
MTNR1B P49286 1/20 0.51
EGFR P00533 7/20 0.48
ERBB3 P21860 2/20 0.48
JAK3 P52333 10/20 0.47
ERBB2 P04626 3/20 0.47
ERBB4 Q15303 2/20 0.47
MEN1 O00255 2/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
KMT2A Q03164 2/20 0.46
JAK1 P23458 8/20 0.44
LPAR1 Q92633 1/20 0.44
LPAR2 Q9HBW0 1/20 0.44
LPAR3 Q9UBY5 1/20 0.44
JAK2 O60674 3/20 0.44
ALDH1A1 P00352 1/20 0.44
BTK Q06187 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12262344 0.88 EGFR (0.57) EGFRERBB3JAK3ERBB2MEN1
SCHEMBL691610 0.87 EGFR (0.64) EGFRERBB3JAK3ERBB2ERBB4
SCHEMBL691611 0.87 EGFR (0.64) EGFRERBB3JAK3ERBB2ERBB4
SCHEMBL12282836 0.83 EGFR (0.53) MTNR1AMTNR1BEGFRERBB3ERBB2
SCHEMBL12282888 0.80 EGFR (0.54) EGFRJAK3ERBB2BTK
SCHEMBL12262542 0.80 MEN1 (0.57) EGFRERBB3MEN1NPC1RAB9A
SCHEMBL691983 0.80 EGFR (0.48) EGFRERBB3ERBB2MEN1NPC1
SCHEMBL691980 0.80 EGFR (0.48) EGFRERBB3ERBB2MEN1NPC1
SCHEMBL2202930 0.79 EGFR (0.55) MTNR1AMTNR1BEGFRERBB3MEN1
SCHEMBL2202934 0.79 EGFR (0.55) MTNR1AMTNR1BEGFRERBB3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421538-A1 HETEROARYL COMPOUNDS AND USES THEREOF Avila Therapeutics, Inc. (US) 2012-02-29 EP disclosed
WO-2010123870-A1 HETEROARYL COMPOUNDS AND USES THEREOF AVILA THERAPEUTICS, INC. (US) 2010-10-28 WO disclosed